AU2003213338A1 - Tablet containing pilsicainide hydrochloride (dry) - Google Patents

Tablet containing pilsicainide hydrochloride (dry)

Info

Publication number
AU2003213338A1
AU2003213338A1 AU2003213338A AU2003213338A AU2003213338A1 AU 2003213338 A1 AU2003213338 A1 AU 2003213338A1 AU 2003213338 A AU2003213338 A AU 2003213338A AU 2003213338 A AU2003213338 A AU 2003213338A AU 2003213338 A1 AU2003213338 A1 AU 2003213338A1
Authority
AU
Australia
Prior art keywords
dry
tablet containing
pilsicainide hydrochloride
pilsicainide
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213338A
Inventor
Atsushi Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Publication of AU2003213338A1 publication Critical patent/AU2003213338A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU2003213338A 2002-03-14 2003-03-13 Tablet containing pilsicainide hydrochloride (dry) Abandoned AU2003213338A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-70211 2002-03-14
JP2002070211 2002-03-14
PCT/JP2003/002975 WO2003075919A1 (en) 2002-03-14 2003-03-13 Tablet containing pilsicainide hydrochloride (dry)

Publications (1)

Publication Number Publication Date
AU2003213338A1 true AU2003213338A1 (en) 2003-09-22

Family

ID=27800336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213338A Abandoned AU2003213338A1 (en) 2002-03-14 2003-03-13 Tablet containing pilsicainide hydrochloride (dry)

Country Status (4)

Country Link
JP (1) JPWO2003075919A1 (en)
KR (1) KR20040091135A (en)
AU (1) AU2003213338A1 (en)
WO (1) WO2003075919A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2391093C2 (en) 2003-04-24 2010-06-10 Джаготек Аг Slow-release tablet with specified core geometry
DE102004043863A1 (en) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with local and time-controlled drug release in the gastrointestinal tract
JP5134955B2 (en) * 2004-09-10 2013-01-30 ヤゴテック アクチエンゲゼルシャフト Tablets having a part-time controlled gastrointestinal release action of active ingredients
EP2019669B1 (en) 2006-05-23 2011-11-23 Takeda Pharmaceutical Company Limited Oral preparation comprising pioglitazone
MY149863A (en) 2006-08-03 2013-10-31 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
KR20140087846A (en) * 2012-12-31 2014-07-09 주식회사 삼양바이오팜 Pharmaceutical composition comprising temozolomide with improved stability and process for manufacturing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56156283A (en) * 1980-05-07 1981-12-02 Suntory Ltd 8-substituted pyrrolitidine and its quaternary ammonium salt
EP0722732A1 (en) * 1995-01-24 1996-07-24 Mitsui Toatsu Chemicals, Inc. Long-acting drug formulation containing pyrimidinedione derivatives
RU2189227C2 (en) * 1996-07-12 2002-09-20 Дайити Фармасьютикал Ко., Лтд. Quickly decomposing, pressed in forms materials and method of their preparing

Also Published As

Publication number Publication date
WO2003075919A1 (en) 2003-09-18
JPWO2003075919A1 (en) 2005-06-30
KR20040091135A (en) 2004-10-27

Similar Documents

Publication Publication Date Title
EG25453A (en) Deferacirox dispersible tablets
HK1088584A1 (en) Tablet dispenser
GB0218625D0 (en) Pharmaceutical compounds
AU2003239601A1 (en) Integrated access device
AU2003298776A1 (en) Mannose-based fast dissolving tablets
GB0215775D0 (en) Pharmaceutical compounds
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
HUP0303948A2 (en) Solid orally-dispersible pharmaceutical formulation
AU2003289154A1 (en) Analyzing device
AU2003213338A1 (en) Tablet containing pilsicainide hydrochloride (dry)
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003231391A1 (en) Integrating device
AU2003228598A1 (en) Musculoskeletal loading device
AU2003279883A1 (en) Device enclosure
AU2003280387A1 (en) Pharmaceutical formulation comprising azithrocycin monohydrate
AU2003213337A1 (en) Tablet containing pilsicainide hydrochloride (wet)
AU2003213948A1 (en) Stable tablets comprising simvastatin
AU2003226681A1 (en) Tablet box
AU2003216089A1 (en) Analysis device
AU2003238590A1 (en) Tablets comprising ciprofloxacin hydrochloride
AU2003215461A1 (en) Stable tablets comprising pergolide mesylate
AU2003281593A1 (en) Analyzing device
AU2002951543A0 (en) Condition analysis
AU2003238900A1 (en) Pharmaceutical formulation
AU2003207055A1 (en) Novel drugs for external use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase